Zum Stellenwert der Diuretika
bei der Hypertoniebehandlung

1 Burke T A, Sturkenboom M C, Lu S E. et al . Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens. 2006; 24 1193-1200
2 Chobanian A V, Bakris G L, Black H R. et al . Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003; 289 2560-2572
3 Corrao G, Zambon A, Parodi A. et al . Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens. 2008; 26 819-824
4 Dahlof B, Sever P S, Poulter N R. et al, ASCOT Investigators . Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005; 366 895-906
5 Davis B R, Cutler J A, Furberg C D. et al . Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Ann Intern Med. 2002; 137 313-320
6 Düsing R. Alte oder neue Antihypertensiva? Konsequenzen aus „ALLHAT“. Dtsch Med Wochenschr. 2003; 128 214-216
7 Düsing R. Diuretika, Pharmakologie und therapeutischer Einsatz. Medizinisch-pharmakologisches Kompendium,. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1986 ISBN 3–8047–0754–8
8 Düsing R. Optimizing blood pressure control through the use of fixed combinations. Vasc Health Risk Manag. 2010; 6 321-325
9 Düsing R. Therapie der Hypertonie mit Diuretika: Wirksamkeit, Sicherheit und Verträglichkeit. Internist. 2011; DOI: 10.1007/s00108–011–2915–3
10 Ernst M, Moser M. Use of diuretics in patients with hypertension. N Engl J Med. 2009; 361 2153-2164
11 Guidelines Committee . 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21 1011-1053
12 Hypertension Detection and Follow-up Program Cooperative Group . Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979; 242 2562-2571
13 Jamerson K, Weber M A, Bakris G L. et al . Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008; 359 2417-2428
14 Mancia G, Laurent S, Agabiti-Rosei E. et al . Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009; 27 2121-2158
15 Messerli F H, Makani H, Benjo A. et al . Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring. J Am Coll Cardiol. 2011; 57 590-600
16 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA. 1977; 237 255-261
17 SHEP Cooperative Research Group . Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265 3255-3264
18 The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1980; 140 1280-1285
19 The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1984; 144 1045-1057
20 The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988; 148 1023-1038
21 The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group . Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting-enzyme inhibitor or calcium channel blocker vs. diuretic. JAMA. 2002; 288 2981-2997
22 The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group . Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2000; 283 1967-1975
23 The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993; 153 154-183
24 The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157 2413-2446
25 The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the Management of Arterial Hypertension. J Hypertens. 2007; 25 1105-1187
26 VA Cooperative Study Group . Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967; 202 1028-1034
27 VA Cooperative Study Group . Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970; 213 1143-1152
28 Wald D S, Law M, Morris J K. et al . Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009; 122 290-300
29 Williams B, Poulter N R, Brown M J, Davis M, McInnes G T, Potter J F, Sever P S, Thom S McG. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. Journal of Human Hypertension. 2004; 18 139-185
30 http://www.nice.org.uk/guidance/CG34
31 Partial update of Clinical Guideline 18 and 34 „Hypertension: The clinical management of primary hypertension in adults. Clinical Guideline. Methods, evidence and recommendations, May 2011. http://www.nice.org.uk

Prof. Dr. med. Rainer Düsing

Medizinische Klinik und Poliklinik 1

Wilhelmstr. 35–37

53111 Bonn

Phone: 0228/287-22343

Fax: 0228/287-22593

Email: duesing@uni-bonn.de